Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment
Background: Nitric oxide (NO) and prostanoids are mediators of vascular and bronchial tone that are postulated to be involved in asthma. Increased levels of both are found in asthmatic subjects and are synthesised by enzymes that have cytokine inducible forms: inducible NO synthase (iNOS) and cyclo-oxygenase-2 (COX-2), respectively. We hypothesised that the in vivo expression of iNOS and COX-2 in the airways would be increased in asthma, and that these cytokine inducible enzymes may represent targets for regulation by corticosteroid treatment.
Methods: Bronchial biopsy specimens were obtained from three groups of subjects: atopic asthmatics treated with beta 2 agonists alone (n=7), atopic asthmatics additionally receiving regular treatment with corticosteroids (n=8), and non-asthmatic control subjects (n=10). Expression of iNOS and COX-2 mRNA and immunoreactive protein was studied using in situ hybridisation and quantitative immunohistochemistry.
Results: Immunoreactivity and the hybridisation signal for iNOS and COX-2 were mainly localised in the airway epithelium. The proportion of epithelium immunostained was significantly greater in the non-steroid treated asthmatic subjects (iNOS 8.6 (1.8)%; COX-2 26.3 (4.6)%) than either the steroid treated asthmatics (iNOS 3.4 (1.0)%, p=0.009; COX-2 13.0 (0.6)%, p=0.0015) or the non-asthmatic controls (iNOS 4.2 (0.9)%, p=0.018; COX-2 11.6 (0.6)%, p=0.0003). Similarly, the hybridisation signal was stronger in the non-steroid treated group of asthmatic subjects than in the other two groups.
Conclusions: These findings highlight the potential role of the airway epithelium both as a contributor to the inflammatory process in asthma and as a target for inhaled corticosteroid treatment in this disease.
asthma, corticosteroids, immunohistochemistry, in situ hybridisation, nitric oxide synthase, cyclo-oxygenase (cox)
351-357
Redington, A.E.
ecaab7c4-c44f-4f52-899a-18993a796c2e
Meng, Q.H.
8a67b552-1e80-47ba-8e14-efe1e623d5a2
Springall, D.R.
54d58170-5da4-40ae-9508-851c87e82263
Evans, T.J.
b8da1a1f-ec30-40f4-99cb-31baada1f84d
Creminon, C.
20d6fabd-eed4-40d0-9bf1-92a1848ec489
Maclouf, J.
0ad51b9a-142c-4bd3-a4ff-e596e4788767
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Howarth, P.H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Polak, J.M.
efd2c2a2-a84d-4daa-9556-cde9e227c7d9
May 2001
Redington, A.E.
ecaab7c4-c44f-4f52-899a-18993a796c2e
Meng, Q.H.
8a67b552-1e80-47ba-8e14-efe1e623d5a2
Springall, D.R.
54d58170-5da4-40ae-9508-851c87e82263
Evans, T.J.
b8da1a1f-ec30-40f4-99cb-31baada1f84d
Creminon, C.
20d6fabd-eed4-40d0-9bf1-92a1848ec489
Maclouf, J.
0ad51b9a-142c-4bd3-a4ff-e596e4788767
Holgate, S.T.
2e7c17a9-6796-436e-8772-1fe6d2ac5edc
Howarth, P.H.
ff19c8c4-86b0-4a88-8f76-b3d87f142a21
Polak, J.M.
efd2c2a2-a84d-4daa-9556-cde9e227c7d9
Redington, A.E., Meng, Q.H., Springall, D.R., Evans, T.J., Creminon, C., Maclouf, J., Holgate, S.T., Howarth, P.H. and Polak, J.M.
(2001)
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment.
Thorax, 56 (5), .
(doi:10.1136/thorax.56.5.351).
Abstract
Background: Nitric oxide (NO) and prostanoids are mediators of vascular and bronchial tone that are postulated to be involved in asthma. Increased levels of both are found in asthmatic subjects and are synthesised by enzymes that have cytokine inducible forms: inducible NO synthase (iNOS) and cyclo-oxygenase-2 (COX-2), respectively. We hypothesised that the in vivo expression of iNOS and COX-2 in the airways would be increased in asthma, and that these cytokine inducible enzymes may represent targets for regulation by corticosteroid treatment.
Methods: Bronchial biopsy specimens were obtained from three groups of subjects: atopic asthmatics treated with beta 2 agonists alone (n=7), atopic asthmatics additionally receiving regular treatment with corticosteroids (n=8), and non-asthmatic control subjects (n=10). Expression of iNOS and COX-2 mRNA and immunoreactive protein was studied using in situ hybridisation and quantitative immunohistochemistry.
Results: Immunoreactivity and the hybridisation signal for iNOS and COX-2 were mainly localised in the airway epithelium. The proportion of epithelium immunostained was significantly greater in the non-steroid treated asthmatic subjects (iNOS 8.6 (1.8)%; COX-2 26.3 (4.6)%) than either the steroid treated asthmatics (iNOS 3.4 (1.0)%, p=0.009; COX-2 13.0 (0.6)%, p=0.0015) or the non-asthmatic controls (iNOS 4.2 (0.9)%, p=0.018; COX-2 11.6 (0.6)%, p=0.0003). Similarly, the hybridisation signal was stronger in the non-steroid treated group of asthmatic subjects than in the other two groups.
Conclusions: These findings highlight the potential role of the airway epithelium both as a contributor to the inflammatory process in asthma and as a target for inhaled corticosteroid treatment in this disease.
This record has no associated files available for download.
More information
Published date: May 2001
Keywords:
asthma, corticosteroids, immunohistochemistry, in situ hybridisation, nitric oxide synthase, cyclo-oxygenase (cox)
Identifiers
Local EPrints ID: 27349
URI: http://eprints.soton.ac.uk/id/eprint/27349
ISSN: 0040-6376
PURE UUID: f833ffcc-0658-4cb9-8610-6723b86d88d1
Catalogue record
Date deposited: 27 Apr 2006
Last modified: 15 Mar 2024 07:18
Export record
Altmetrics
Contributors
Author:
A.E. Redington
Author:
Q.H. Meng
Author:
D.R. Springall
Author:
T.J. Evans
Author:
C. Creminon
Author:
J. Maclouf
Author:
J.M. Polak
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics